Clinical Risk Factors for Fracture in Diabetes: A Matched Cohort Analysis

Journal of Clinical Densitometry

Volumn 14, Issue 4, 2011, Pages 416-421

  Fraser, Lisa Ann ^a,b   Pritchard, Janet ^b   Ioannidis, George ^b   Giangegorio, Lora M ^c   Adachi, Jonathan D ^b   Papaioannou, Alexandra ^b   Leslie, William D ^d  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c UNIVERSITY OF WATERLOO   (Canada)

^d UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Clinical risk factor; Diabetes; Fracture; Osteoporosis

Indexed keywords

CORTICOSTEROID;

ADULT; AGED; ARTICLE; BONE DENSITY; CANADA; CLINICAL RISK FACTOR; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DATA BASE; DEMOGRAPHY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; FRAGILITY FRACTURE; HAZARD RATIO; HEALTH PROGRAM; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT;

ACCIDENTAL FALLS; AGED; CASE-CONTROL STUDIES; DIABETES MELLITUS; DIABETIC NEUROPATHIES; FEMALE; HUMANS; MANITOBA; OSTEOPOROTIC FRACTURES; RISK FACTORS;

EID: 82855175183     PISSN: 10946950     EISSN: 15590747     Source Type: Journal    
DOI: 10.1016/j.jocd.2011.06.007     Document Type: Article

References (24)

1. Vestergaard P. Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes-a meta-analysis. Osteoporos Int 2007, 18:427-444.
2. Leslie W.D., Lix L.M., Prior H.J., et al. Biphasic fracture risk in diabetes: a population-based study. Bone 2007, 40:1595-1601.
3. Vestergaard P., Rejnmark L., Mosekilde L. Relative fracture risk in patients with diabetes mellitus, and the impact of insulin and oral antidiabetic medication on relative fracture risk. Diabetologia 2005, 48:1292-1299.
4. Yamamoto M.Y.T., Yamauchi M., Kaji H., Sugimoto T. Diabetic patients have an increased risk of vertebral fractures independent of BMD or diabetic complications. J Bone Miner Res 2009, 24:702-770.
5. Melton L.J., Leibson C.L., Achenbach S.J., et al. Fracture risk in type 2 diabetes: update of a population-based study. J Bone Miner Res 2008, 23:1334-1342.
6. Hein G., Weiss C., Lehmann G., et al. Advanced glycation end product modification of bone proteins and bone remodelling: hypothesis and preliminary immunohistochemical findings. Ann Rheum Dis 2006, 65:101-104.
7. Merlotti D., Gennari L., Dotta F., et al. Mechanisms of impaired bone strength in type 1 and type 2 diabetes. Nutr Metab Cardiovasc Dis 2010, 20:683-690.
8. Hofbauer L.C., Brueck C.C., Singh S.K., Dobnig H. Osteoporosis in patients with diabetes mellitus. J Bone Miner Res 2007, 22:1317-1328.
9. de Liefde, van der Klift M., de Laet C.E., et al. Bone mineral density and fracture risk in type-2 diabetes mellitus: the Rotterdam Study. Osteoporos Int 2005, 16:1713-1720.
10. Leslie W.D., Lix L.M., Langsetmo L., et al. Construction of a FRAX® model for the assessment of fracture probability in Canada and implications for treatment. Osteoporos Int 2011, 22:829-837.
11. CDA The prevalence and cost of diabetes [article online], Available at:, Accessed January 7, 2011. http://www.diabetes.ca.
12. Ford E.S., Williamson D.F., Liu S. Weight change and diabetes incidence: findings from a national cohort of US adults. Am J Epidemiol 1997, 146:214-222.
13. Kanis J.A., Johnell O., Oden A., et al. FRAX and the assessment of fracture probability in men and women from the UK. Osteoporos Int 2008, 19:385-397.
14. Roos L.L., Mustard C.A., Nicol J.P., et al. Registries and administrative data: organization and accuracy. Med Care 1993, 31:201-212.
15. Leslie W.D., Caetano P.A., MacWilliam L.R., Finlayson G.S. Construction and validation of a population-based bone densitometry database. J Clin Densitom 2005, 8:25-30.
16. Blanchard J.F., Ludwig S., Wajda A., et al. Incidence and prevalence of diabetes in Manitoba 1986-1991. Diabetes Care 1996, 27:1047-1053.
17. Looker A.C., Wahner H.W., Dunn W.L., et al. Updated data on proximal femur bone mineral levels of US adults. Osteoporos Int 1998, 8:468-489.
18. Kanazawa I., Yamaguchi T., Yamamoto M., et al. Combination of obesity with hyperglycemia is a risk factor for the presence of vertebral fractures in type 2 diabetic men. Calcif Tissue Int 2008, 83:324-331.
19. Yamaguchi T.K.I., Yamamoto M., Karioka S., et al. Associations between components of the metabolic syndrome versus bone mineral density and vertebral fractures in patients with type 2 diabetes. Bone 2009, 45:174-179.
20. Patel S., Hyer S., Tweed K., et al. Risk factors for fractures and falls in older women with type 2 diabetes mellitus. Calcif Tissue Int 2008, 82:87-91.
21. Ivers R.Q., Cumming R.G., Mitchell P., Peduto A.J. Diabetes and risk of fracture: the Blue Mountains Eye Study. Diabetes Care 2001, 24:1198-1203.
22. McCabe L.R. Understanding the pathology and mechanisms of type 1 diabetic bone loss. J Cell Biochem 2007, 102:1343-1357.
23. Irwin R., Lin H.V., Motyl K.J., McCabe L.R. Normal bone density obtained in the absence of insulin receptor expression in bone. Endocrinology 2006, 147:5760-5767.
24. Kahn S.E., Zinman B., Lachin J.M., et al. Rosiglitazone-associated fractures in type 2 diabetes: an analysis from A Diabetes Outcome Progression Trial (ADOPT). Diabetes Care 2008, 31:845-851. Diabetes Outcome Progression Trial (ADOPT) Study Group.